Davenport & CO LLC Vertex Pharmaceuticals Inc Transaction History

Davenport & CO LLC

$16.8 Billion
Q3 2024

A detailed history of Davenport & CO LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Davenport & CO LLC holds 219,709 shares of VRTX stock, worth $99.1 Million. This represents 0.61% of its overall portfolio holdings.

Number of Shares

219,709

Previous 221,525 0.82%

Holding current value

$99.1 Million

Previous $104 Million 1.59%

% of portfolio

0.61%

Previous 0.65%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$460.0 - $505.78 $835,360 - $918,496	-1,816 Reduced 0.82%	219,709 $102 Million
Q2 2024 Aug 06, 2024	BUY	$392.81 - $485.53 $1.07 Million - $1.33 Million	2,734 Added 1.25%	221,525 $104 Million
Q1 2024 May 03, 2024	SELL	$407.69 - $446.08 $182,237 - $199,397	-447 Reduced 0.2%	218,791 $91.5 Million
Q4 2023 Jan 23, 2024	BUY	$343.0 - $410.68 $35.6 Million - $42.6 Million	103,769 Added 89.87%	219,238 $89.2 Million
Q3 2023 Oct 17, 2023	SELL	$338.18 - $362.46 $149,475 - $160,207	-442 Reduced 0.38%	115,469 $40.2 Million
Q2 2023 Jul 20, 2023	BUY	$314.42 - $351.91 $31.9 Million - $35.7 Million	101,567 Added 708.08%	115,911 $40.8 Million
Q1 2023 Apr 27, 2023	SELL	$283.23 - $323.1 $111,592 - $127,301	-394 Reduced 2.67%	14,344 $4.52 Million
Q4 2022 Jan 20, 2023	BUY	$285.76 - $321.48 $44,864 - $50,472	157 Added 1.08%	14,738 $0
Q3 2022 Oct 11, 2022	SELL	$273.83 - $305.53 $1.72 Million - $1.92 Million	-6,284 Reduced 30.12%	14,581 $4.22 Million
Q2 2022 Jul 18, 2022	SELL	$234.96 - $292.55 $330,118 - $411,032	-1,405 Reduced 6.31%	20,865 $5.88 Million
Q1 2022 May 02, 2022	BUY	$221.42 - $260.97 $343,865 - $405,286	1,553 Added 7.5%	22,270 $5.81 Million
Q4 2021 Feb 10, 2022	BUY	$177.01 - $223.45 $410,309 - $517,957	2,318 Added 12.6%	20,717 $4.55 Million
Q3 2021 Oct 14, 2021	BUY	$181.39 - $202.99 $230,728 - $258,203	1,272 Added 7.43%	18,399 $3.34 Million
Q2 2021 Jul 28, 2021	SELL	$187.49 - $221.1 $23.3 Million - $27.5 Million	-124,507 Reduced 87.91%	17,127 $3.45 Million
Q1 2021 Apr 28, 2021	BUY	$207.02 - $241.31 $1.78 Million - $2.07 Million	8,598 Added 6.46%	141,634 $30.4 Million
Q4 2020 Jan 13, 2021	BUY	$207.01 - $276.09 $27.1 Million - $36.2 Million	131,123 Added 6854.31%	133,036 $31.4 Million
Q3 2020 Oct 15, 2020	BUY	$255.65 - $303.1 $489,058 - $579,830	1,913 New	1,913 $521,000

Others Institutions Holding VRTX

# of Institutions

1,723

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Davenport & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Davenport & CO LLC with notifications on news.

Account